Nuclear Medicine Communications · 2018 · 12 citations · 23 references
MedicineOncologySurgeryGynecologic OncologyOncologic ImagingSurgical OncologyGynecologic Oncology SurgeryMalignant NeoplasmsOvarian CancerPreoperative Oncology AssessmentTumor CharacterizationTumor ImagingHigh-grade Serous Ovarian CarcinomaMetabolic Tumor VolumePet-computed TomographyPositron Emission Tomography PrognosisPreoperative Cancer ImagingPreoperative Tumor CharacterizationSerous Ovarian TumorsTotal Lesion Glycolysis
OBJECTIVE: This study aimed to explore the clinical and prognostic significance of pretreatment positron-emission tomography/computed tomography (PET/CT) parameters, especially 2-deoxy-2-(F)fluoro-D-glucose-based heterogeneity, in high-grade serous ovarian cancer (HGSC). MATERIALS AND METHODS: We retrospectively investigated 56 patients with HGSC who underwent PET/CT before primary surgery at our hospital between January 2010 and June 2015. None of these patients received neoadjuvant chemotherapy. PET/CT parameters, including maximum and mean standardized uptake value (SUVmax and SUVmean), metabolic tumor volume (MTV), total lesion glycolysis (TLG), and intratumoral heterogeneity index (HI), were measured for all patients. Differences of each PET/CT parameter between primary tumors (-P) and omental metastatic lesions (-M) were compared by paired t tests. Progression-free survival (PFS) and overall survival were analyzed by the Kaplan-Meier method and log-rank tests in univariate analyses. Cox regression analyses were used for multivariate analysis. RESULTS: SUVmean-P was higher than SUVmean-M (P=0.001). However, there were no statistical differences of SUVmax, MTV, TLG, or HI between primary and omental lesions. Chemosensitive patients tended to have higher levels of SUVmax-P (P=0.011), MTV-P (P=0.014), TLG-P (P=0.035), and HI-P (P=0.002), respectively. In univariate analyses, higher HI-P was associated with better PFS (P=0.007). However, in multivariate analysis, HI-P was not an independent predictor of PFS (P=0.581). Neither HI-P nor HI-M was the prognostic predictor for overall survival (P=0.078 and 0.063, respectively). CONCLUSION: 2-Deoxy-2-(F)fluoro-D-glucose-based heterogeneity appears to be a predictive and prognostic factor for patients with HGSC. Parameters of primary tumors have predominant value compared with omental metastatic lesions.
23
Global cancer statistics, 2012
Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2015 · 27.4K citations · Full text
Florent Tixier, Catherine Cheze Le Rest, Mathieu Hatt et al. · Journal of Nuclear Medicine · 2011 · 684 citations · Full text
Medicine, Nuclear Medicine, Oncology +17
Exploring feature-based approaches in PET images for predicting cancer treatment outcomes
Perry W. Grigsby, Aditya Apte, Elizabeth Kidd et al. · Pattern Recognition · 2008 · 471 citations · Full text
Gary Cook, Connie Yip, Muhammad Siddique et al. · Journal of Nuclear Medicine · 2012 · 394 citations · Full text
Medicine, Nuclear Medicine, Oncology +17